Clinical Trials Directory

Trials / Completed

CompletedNCT04718311

Study on Treatment for Patients With Symptomatic Oral Lichen Planus

Analysis of Two Treatment Protocols for Patients With Oral Lichen Planus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Catania · Academic / Other
Sex
All
Age
25 Years – 70 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study was to compare the therapeutic efficacy of Tacrolimus gel versus an anti-inflammatory mouthwash in an oral solution for the management of patients suffering from symptomatic OLP. The secondary objective was to analyze which one of the two treatments induced a greater risk of developing side effects.

Detailed description

Thirty nine patients were assigned, through a randomized design, to receive tacrolimus ointment 0.1% or a mouthwash composed of calcium hydroxide 10%, hyaluronic acid 0,3%, umbelliferone and oligomeric proanthocyanidins, or an anti-inflammatory mouthwash (mouthwash which contains calcium hydroxide, hyaluronic acid, Umbelliferone and Oligomeric Proanthocyanidins) for 3-months. At baseline (T0) and after 3 months (T1), patients were subjected to clinical and oral assessments and were evaluated for the symptoms (Numerical Pain Scale, NRS score) and signs (Thongprasom's score) of OLP. Data were calculated using T-test for the dependent variable, Wilcoxon test and Mann-Witney u test.

Conditions

Interventions

TypeNameDescription
DRUGOral lichen clinical Healing evaluationTreatments were topically applied for 5 days

Timeline

Start date
2019-01-02
Primary completion
2020-03-05
Completion
2020-03-20
First posted
2021-01-22
Last updated
2021-01-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04718311. Inclusion in this directory is not an endorsement.